Strong Patent Protections Under TPP Would Allow Increased Drug Access In LMICs

Forbes: Intellectual Property Rights For Global Health
John R. Graham, senior fellow at the National Center for Policy Analysis and the Independent Institute

“…Unfortunately, attacking patents is a misguided way to improve access to medicines in low- and middle-income [countries]. Although it is a counter-intuitive conclusion, strong patent rights are a better way to achieve this goal. In an international environment of strong patent rights, innovative drug makers would have every incentive to lower prices voluntarily to poor countries. … [T]he best way for poor countries to improve access to safe and innovative medicines is by adopting policies that allow them to create wealth. That includes strong patent protection. Giving [President Obama] Fast Track authority to negotiate a [Trans-Pacific Partnership (TPP)] with poor patent protection would harm both American innovators and patients in low- and middle-income countries” (4/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.